Artym Vira V, Zhang Ying, Seillier-Moiseiwitsch Françoise, Yamada Kenneth M, Mueller Susette C
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical School, Washington, District of Columbia 20057-1469, USA.
Cancer Res. 2006 Mar 15;66(6):3034-43. doi: 10.1158/0008-5472.CAN-05-2177.
Metastatic tumor cells that actively migrate and invade surrounding tissues rely on invadopodia to degrade extracellular matrix (ECM) barriers. Invadopodia are membrane protrusions that localize enzymes required for ECM degradation. Little is known about the formation, function, and regulation of invadopodia. Here, we show that invadopodia have two distinct aspects: (a) structural for organizing the cellular actin cytoskeleton to form membrane protrusions and (b) functional for using proteolytic enzyme(s) for ECM degradation. Small interfering RNA (siRNA) inhibition established that organization of invadopodia structure requires cortactin, whereas protease inhibitor studies identified membrane type 1 matrix metalloproteinase (MT1-MMP) as the key invadopodial enzyme responsible for gelatin matrix degradation in the breast carcinoma cell line MDA-MB-231. The inhibition of invadopodial structure assembly by cortactin depletion resulted in a block of matrix degradation due to failure of invadopodia formation. Either protease inhibition or MT1-MMP siRNA depletion moderately decreased the formation of invadopodial structures that were identified as actin-cortactin accumulations at the ventral cell membrane adherent to matrix. The invadopodia that were able to form upon MT1-MMP inhibition or depletion retained actin-cortactin accumulations but were unable to degrade matrix. Examination of cells at different time points as well as live-cell imaging revealed four distinct invadopodial stages: membrane cortactin aggregation at membranes adherent to matrix, MT1-MMP accumulation at the region of cortactin accumulation, matrix degradation at the invadopodia region, and subsequent cortactin dissociation from the area of continued MT1-MMP accumulation associated with foci of degraded matrix. Based on these results, we propose a stepwise model of invadopodia formation and function.
积极迁移并侵袭周围组织的转移性肿瘤细胞依靠侵袭伪足来降解细胞外基质(ECM)屏障。侵袭伪足是一种膜性突起,它定位了ECM降解所需的酶。目前对于侵袭伪足的形成、功能及调控了解甚少。在此,我们表明侵袭伪足有两个不同的方面:(a)结构方面,用于组织细胞肌动蛋白细胞骨架以形成膜性突起;(b)功能方面,用于利用蛋白水解酶进行ECM降解。小干扰RNA(siRNA)抑制实验证实,侵袭伪足结构的组织需要皮层肌动蛋白,而蛋白酶抑制剂研究确定膜型1基质金属蛋白酶(MT1-MMP)是负责乳腺癌细胞系MDA-MB-231中明胶基质降解的关键侵袭伪足酶。皮层肌动蛋白缺失导致侵袭伪足结构组装受到抑制,进而由于侵袭伪足无法形成而导致基质降解受阻。蛋白酶抑制或MT1-MMP siRNA缺失均适度减少了侵袭伪足结构的形成,这些结构被确定为在粘附于基质的腹侧细胞膜处的肌动蛋白-皮层肌动蛋白聚集。在MT1-MMP抑制或缺失时能够形成的侵袭伪足保留了肌动蛋白-皮层肌动蛋白聚集,但无法降解基质。对不同时间点的细胞进行检查以及活细胞成像显示出四个不同的侵袭伪足阶段:在粘附于基质的膜处形成膜皮层肌动蛋白聚集,在皮层肌动蛋白聚集区域积累MT1-MMP,在侵袭伪足区域进行基质降解,以及随后皮层肌动蛋白从与降解基质灶相关的持续MT1-MMP积累区域解离。基于这些结果,我们提出了一个侵袭伪足形成和功能的逐步模型。